Nonbinary Doctor Sues NYC Health for Alleged Discrimination

Mar 28, 2026, 2:43 AM
Image for article Nonbinary Doctor Sues NYC Health for Alleged Discrimination

Hover over text to view sources

Danielle Peterson, a former dermatology resident, has filed a federal lawsuit against NYC Health and Hospitals, alleging a pattern of gender-based discrimination and harassment that ultimately led to their removal from the residency program at Metropolitan Hospital Center in Manhattan.
The lawsuit, submitted on March 23, claims violations of both state and city human rights laws, specifically citing gender identity discrimination, disability discrimination, and retaliation. Peterson alleges that the program's director, Dr Marian Russo, instructed them to keep their nonbinary identity and pronouns secret, effectively creating a condition of employment that mandated concealment of their gender identity.
The complaint details a workplace atmosphere rife with hostility and discrimination. For instance, Department Chair Dr Bijan Safai allegedly expressed skepticism regarding Peterson's credentials, claiming they had "tricked" the program during the interview process. Additionally, faculty members reportedly made derogatory comments about nonbinary individuals, with one faculty member asking how Peterson could ascertain a patient's gender and jokingly referring to transgender individuals as "perverts.".
The situation escalated in November 2024 when Dr Safai demanded that Peterson undergo an internal psychiatric evaluation, suggesting that there was "something mentally wrong" with them. This demand reportedly followed Peterson's disclosure of their nonbinary identity during a confrontation with Dr Safai, who allegedly responded with an inappropriate anecdote about a transgender man, implying that Peterson would become "ugly" if they transitioned.
Despite seeking external evaluations from two independent doctors who cleared Peterson for clinical duties, they were removed from all responsibilities for a month. Peterson's lawsuit highlights procedural irregularities, such as the lack of a Performance Improvement Plan, which goes against the institution's own policies.
The complaint also notes that Peterson was denied access to their personnel file, a right they were entitled to under their contract, which raises further questions about the institution's adherence to proper HR procedures.
The final decision to not renew Peterson's contract was made on April 24, 2025, citing unsatisfactory completion of a remediation plan and a lack of professionalism, despite evidence suggesting that this plan was not communicated effectively or in a timely manner.
As part of the lawsuit, Peterson is seeking damages and has requested a jury trial. The actions outlined in their complaint reflect broader issues regarding workplace discrimination against nonbinary and transgender individuals, particularly within medical and educational institutions.
NYC Health and Hospitals has yet to respond publicly to the lawsuit.
This case underscores the ongoing challenges faced by nonbinary individuals in professional settings, particularly in fields such as medicine, where inclusion and respect for gender identity are crucial for fostering a supportive work environment.
In New York City, discrimination based on gender identity is prohibited under the New York City Human Rights Law, which aims to protect individuals from harassment and discrimination in various domains, including employment. The outcome of this lawsuit could have significant implications for policies regarding gender identity and inclusion in medical institutions moving forward.

Related articles

Transforming Mental Health Care Access for Alaska's Youth

Alaska faces a mental health crisis among its youth, with suicide being the leading cause of death for ages 15-24. House Bill 232 aims to empower adolescents aged 16-17 by allowing them to access mental health care without parental consent, addressing barriers that currently prevent many from seeking help.

FDA Cracks Down on Telehealth Firms Over Compounded GLP-1 Products

The FDA has issued 30 warning letters to telehealth companies for misleading claims about compounded GLP-1 drugs. This action is part of a broader effort to regulate the marketing practices of telehealth firms and ensure patient safety.

Health Officials Urge Measles Vaccine Checks Amid Rising Cases

Health officials are warning of a surge in measles cases across the US, urging individuals to verify their vaccination status. Recent outbreaks, primarily among unvaccinated populations, highlight the importance of the MMR vaccine in preventing this highly contagious disease.

CDC Health Alerts Drop Leaves Doctors 'Flying Blind'

A significant reduction in health alerts from the CDC has raised concerns among healthcare professionals about preparedness and response to health risks. With only six alerts issued in 2025, doctors feel unprepared for emerging health threats like flu and measles.

Flu Activity in the U.S. Expected to Rise for Weeks, CDC Warns

Flu activity in the United States is projected to continue increasing over the coming weeks, according to Dr Carrie Reed from the CDC. Current estimates indicate over 11 million illnesses and a new variant, subclade K, is now the dominant strain. Health officials emphasize the importance of vaccination and early treatment with antivirals for those at higher risk.